By broadening definition of success to include sustained low-level HBsAg with suppressed HBV DNA, we can recognize clinically ...

Please provide your email address to receive an email when new articles are posted on . The highest percentages of patients with HBsAg loss were observed in the groups that received xalnesiran plus an ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Up to 19% of patients who received JNJ-3989 achieved ...

Background PD-1 blockade has emerged as a promising approach for functional cure of chronic hepatitis B (CHB). Objective This study aimed to evaluate the safety profile of anti-PD-1 antibody (αPD-1), ...

Patients with chronic hepatitis B virus (HBV) infection in the immune-tolerant phase may still experience hepatic inflammation and disease progression, and could benefit from early antiviral treatment ...

Professor of Medicine and Chief, Division of Hepatology, Center for Liver Disease, University of Miami School of Medicine, Miami, Florida Antiviral studies generally used intermediate markers of ...

Phase Ib study combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with CD20-positive B-cell non-Hodgkin lymphoma (NHL). This is an ASCO ...

If a doctor suspects that a person may have hepatitis B, they will likely order a single blood test to check for the condition. This test is called a hepatitis B titer panel, and it consists of three ...

A screening test can determine if a person has an infection with hepatitis B. It involves a blood test that detects antigens and antibodies for hepatitis B virus (HBV). Hepatitis B, or hep B, is a ...